Union européenne - français - EMA (European Medicines Agency)

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

Canada - français - Health Canada

mirum pharmaceuticals, inc. - maralixibat (chlorure de maralixibat) - solution - 9.5mg - maralixibat (chlorure de maralixibat) 9.5mg